ACA Marketplace insurers are requesting a median premium increase of 6% for 2024, according to a new KFF analysis of the preliminary rate filings. Insurers’ proposed rate changes – most of which fall between 2% and 10% – may change during the review pr…
In their early rate filings, Marketplace insurers are requesting a median premium increase of 6% for 2024, which they say is largely due to price increases for medical care and prescription drugs.
In their early rate filings, Marketplace insurers are requesting a median premium increase of 6% for 2024, which they say is largely due to price increases for medical care and prescription drugs.
This analysis of insurers’ preliminary rate filings shows that ACA Marketplace insurers are requesting a median premium increase of 6% for 2024. Insurers cite price increases for medical care and prescription drugs as a key driver of premium growth in …
About half of adults are interested in taking prescription weight loss drugs. though interest drops when presented with obstacles or drawbacks. Many adults struggle with affording prescription drugs and say there should be more price regulation. Few ar…
Nearly half (45%) of the public are at least somewhat interested in taking a prescription weight-loss drug, including many who say they only want to lose a little weight, though many people lose interest when presented with potential financial and medi…
Prices for medical services typically rise more quickly than the broader economy, but the reverse has been true recently as general inflation rose rapidly. This analysis finds that overall prices grew by 6% in February 2023 from the previous year, whil…
This chart collection takes a deep dive into employment data to analyze how health sector jobs and wages shrank and recovered since the coronavirus pandemic struck in early 2020.
This analysis finds that privately insured adults who were treated for depression and/or anxiety in 2021 spent almost twice as much on annual out-of-pocket costs compared to enrollees who were not treated for a mental health diagnosis.
This analysis finds that privately insured adults who were treated for depression and/or anxiety in 2021 spent almost twice as much on annual out-of-pocket costs compared to enrollees who were not treated for a mental health diagnosis.
